Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-22-004880

Options or other derivatives

  • Chief Executive Officer acquired 423,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Semerjian Harout · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-21 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +423,500 423,500 D
Loading xslF345X03/doc4.xml…